Tocilizumab is a humanized monoclonal antibody that binds to the interleukin-6 receptor. Tocilizumab prevents binding of IL-6 to the IL-6R, thereby inhibiting both classic and trans-signaling. Tocilizumab can be used for the research of rheumatoid arthritis and COVID-19.
Molecular Weight:
144984.63
Purity:
>98%
CAS Number:
[375823-41-9]
Formula:
C6428H9976N1720O2018S42
Target:
IL Receptor/Related
* VAT and and shipping costs not included. Errors and price changes excepted